Sotera Health Company (SHC)
NASDAQ: SHC · Real-Time Price · USD
16.16
-0.56 (-3.35%)
Feb 25, 2026, 4:00 PM EST - Market closed
Sotera Health Company Analyst Ratings
Total Analysts
7
Consensus Rating
Buy
Price Target
$20.67
Upside
+27.91%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $21 → $23 | Strong Buy | Maintains | $21 → $23 | +42.33% | Feb 24, 2026 |
| RBC Capital | RBC Capital | Buy Initiates $24 | Buy | Initiates | $24 | +48.51% | Jan 9, 2026 |
| Piper Sandler | Piper Sandler | Hold → Buy Upgrades $17 → $24 | Hold → Buy | Upgrades | $17 → $24 | +48.51% | Jan 9, 2026 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Dec 18, 2025 |
| BMO Capital | BMO Capital | Buy Initiates $19 | Buy | Initiates | $19 | +17.57% | Nov 13, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $14 → $16 | Hold | Maintains | $14 → $16 | -0.99% | Nov 5, 2025 |
| Barclays | Barclays | Buy Maintains $19 → $20 | Buy | Maintains | $19 → $20 | +23.76% | Nov 5, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $15 → $17 | Hold | Maintains | $15 → $17 | +5.20% | Nov 5, 2025 |
| Barclays | Barclays | Buy Maintains $17 → $19 | Buy | Maintains | $17 → $19 | +17.57% | Oct 2, 2025 |
| Barclays | Barclays | Buy Maintains $15 → $13 | Buy | Maintains | $15 → $13 | -19.55% | Jun 24, 2025 |
| Goldman Sachs | Goldman Sachs | Hold → Strong Buy Upgrades $14 → $17 | Hold → Strong Buy | Upgrades | $14 → $17 | +5.20% | May 5, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $15 → $13 | Hold | Maintains | $15 → $13 | -19.55% | Apr 23, 2025 |
| Barclays | Barclays | Buy Maintains $16 → $12 | Buy | Maintains | $16 → $12 | -25.74% | Apr 10, 2025 |
| Barclays | Barclays | Buy Maintains $17 → $16 | Buy | Maintains | $17 → $16 | -0.99% | Feb 28, 2025 |
| Barclays | Barclays | Buy Maintains $18 → $17 | Buy | Maintains | $18 → $17 | +5.20% | Feb 18, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $17 | Buy | Reiterates | $17 | +5.20% | Nov 21, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.